DK1113811T3 - Kemokinreceptorantagonist og cyclosporin i kombineret terapi - Google Patents

Kemokinreceptorantagonist og cyclosporin i kombineret terapi

Info

Publication number
DK1113811T3
DK1113811T3 DK99948760T DK99948760T DK1113811T3 DK 1113811 T3 DK1113811 T3 DK 1113811T3 DK 99948760 T DK99948760 T DK 99948760T DK 99948760 T DK99948760 T DK 99948760T DK 1113811 T3 DK1113811 T3 DK 1113811T3
Authority
DK
Denmark
Prior art keywords
cyclosporine
receptor antagonist
chemokine receptor
combined therapy
therapy
Prior art date
Application number
DK99948760T
Other languages
English (en)
Inventor
Hermann-Joseph Grone
Peter J Nelson
Amanda Proudfoot
Timothy N C Wells
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK1113811T3 publication Critical patent/DK1113811T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK99948760T 1998-09-18 1999-09-16 Kemokinreceptorantagonist og cyclosporin i kombineret terapi DK1113811T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98117697A EP1000626A1 (en) 1998-09-18 1998-09-18 Chemokine receptor antagonist and cyclosporin in combined therapy
PCT/EP1999/006844 WO2000016796A1 (en) 1998-09-18 1999-09-16 Chemokine receptor antagonist and cyclosporin in combined therapy

Publications (1)

Publication Number Publication Date
DK1113811T3 true DK1113811T3 (da) 2003-03-10

Family

ID=8232654

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99948760T DK1113811T3 (da) 1998-09-18 1999-09-16 Kemokinreceptorantagonist og cyclosporin i kombineret terapi

Country Status (23)

Country Link
US (1) US6902728B1 (da)
EP (2) EP1000626A1 (da)
JP (1) JP2003519082A (da)
KR (1) KR100613950B1 (da)
CN (1) CN1177613C (da)
AR (1) AR021810A1 (da)
AT (1) ATE227582T1 (da)
AU (1) AU766595B2 (da)
BR (1) BR9913846A (da)
CA (1) CA2344370A1 (da)
DE (1) DE69903964T2 (da)
DK (1) DK1113811T3 (da)
EA (1) EA003181B1 (da)
EE (1) EE04705B1 (da)
ES (1) ES2186411T3 (da)
HK (1) HK1041225B (da)
IL (2) IL141899A0 (da)
NO (1) NO20011371D0 (da)
PT (1) PT1113811E (da)
SI (1) SI1113811T1 (da)
UA (1) UA60379C2 (da)
WO (1) WO2000016796A1 (da)
ZA (1) ZA200101909B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259136B2 (en) 1999-04-30 2007-08-21 Amylin Pharmaceuticals, Inc. Compositions and methods for treating peripheral vascular disease
US6740636B2 (en) 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
LT5132B (lt) 2000-07-31 2004-05-25 Schering Aktiengesellschaft Nepeptidiniai ccr1 receptorių antagonistai derinyje su ciklosporinu a širdies transplanto atmetimui gydyti
JP5624884B2 (ja) 2007-08-02 2014-11-12 ノビミューンエスアー 抗rantes抗体およびその使用の方法
WO2017040520A1 (en) 2015-08-31 2017-03-09 Hitachi Chemical Co., Ltd. Molecular methods for assessing urothelial disease
DE112016003951T5 (de) * 2015-08-31 2018-05-30 City Of Sapporo Molekulare verfahren zur beurteilung von komplikationen nach einer nierentransplatation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017935A2 (en) * 1994-12-08 1996-06-13 Glaxo Group Limited Rantes peptide and fragments and compositions comprising it for treatment of inflammation
EP0845994A1 (en) * 1995-08-09 1998-06-10 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
WO1998006703A1 (en) * 1996-08-14 1998-02-19 Warner-Lambert Company 2-phenyl benzimidazole derivatives as mcp-1 antagonists
WO1998006751A1 (en) * 1996-08-16 1998-02-19 Research Corporation Technologies, Inc. Mcp-3, rantes and mip-1alpha receptor antagonists

Also Published As

Publication number Publication date
NO20011371L (no) 2001-03-16
EE04705B1 (et) 2006-10-16
KR20010075060A (ko) 2001-08-09
CN1177613C (zh) 2004-12-01
UA60379C2 (uk) 2003-10-15
IL141899A0 (en) 2002-03-10
DE69903964D1 (en) 2002-12-19
SI1113811T1 (en) 2003-04-30
KR100613950B1 (ko) 2006-08-18
EA200100366A1 (ru) 2001-08-27
ATE227582T1 (de) 2002-11-15
CN1319021A (zh) 2001-10-24
NO20011371D0 (no) 2001-03-16
IL141899A (en) 2007-12-03
ES2186411T3 (es) 2003-05-01
EP1000626A1 (en) 2000-05-17
HK1041225A1 (en) 2002-07-05
EP1113811A1 (en) 2001-07-11
ZA200101909B (en) 2001-09-11
EP1113811B1 (en) 2002-11-13
EA003181B1 (ru) 2003-02-27
US6902728B1 (en) 2005-06-07
AR021810A1 (es) 2002-08-07
CA2344370A1 (en) 2000-03-30
BR9913846A (pt) 2001-06-05
HK1041225B (zh) 2005-04-22
EE200100159A (et) 2002-08-15
AU766595B2 (en) 2003-10-16
DE69903964T2 (de) 2003-03-27
JP2003519082A (ja) 2003-06-17
PT1113811E (pt) 2003-03-31
WO2000016796A1 (en) 2000-03-30
AU6191499A (en) 2000-04-10

Similar Documents

Publication Publication Date Title
NL300395I1 (nl) GnRH antagonisten gemodificeerd in posities 5 en 6
IS6411A (is) Kaspasa tálmar og notkun þeirra
ATE236898T1 (de) S-omeprazol in festform
IS6183A (is) Díamínóþíazol og notagildi þeirra til að hindra prótín kínasa
NO994438L (no) Terapeutisk aktive diarylpropylaminer samt fremstilling og anvendelse derav
FR2823209B1 (fr) Nouvelles thiohydantoines et leur utilisation en therapeutique
ID16283A (id) Senyawa yang berguna dibidang farmasi
NO20004274D0 (no) Proteaseaktivert reseptor 4 og anvendelse derav
DK1113811T3 (da) Kemokinreceptorantagonist og cyclosporin i kombineret terapi
DK0815126T3 (da) Bicykliske tachykinin-antagonister, fremstilling deraf og deres anvendelse i farmaceutiske præparater
DE69822446D1 (de) Cyclosporin derivate und deren verwendung
DE69831522D1 (de) In-situ Zellextraktion und Assay-Verfahren
DE29718591U1 (de) Kipp- und Schwingsitz
MA26894A1 (fr) Agents antihypertenseurs et leur utilisation
GB9906893D0 (en) Stress-forecasting time and magnitude of large earthquakes in stress-monitoring sites
DE29803325U1 (de) Brennstoffzelle sowie Brennstoffzellenanordnung
HU0000744D0 (en) Transposing unit and flaw
NO20021475D0 (no) Vasopressinantagonist, formulering og fremgangsmåte
DE29617001U1 (de) Tablette in Herzform
DE29812381U1 (de) Umrüstbare Steh- und Sitzplatztribüne
FR2780976B1 (fr) Nouveaux agents tensioactifs, et leur utilisation en cosmetique et dermo-pharmacie
PT9466T (pt) Perfil assento de banco e cadeira
TW468434U (en) Combined desk and chair
TW408587U (en) Chair cushion and chair back synchronous swinging construction
DE29616694U1 (de) Verdickungsmittel in Tablettenform